You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

  1. Home
  2. Clinical Information
  3. Performance Measures
  4. HIV/AIDS: Pneumocystis jiroveci pneumonia (PCP) Prophylaxis

HIV/AIDS: Pneumocystis jiroveci pneumonia (PCP) Prophylaxis

    Percentage of patients aged 6 weeks or older with a diagnosis of HIV/AIDS, who were prescribed Pneumocystis jiroveci pneumonia (PCP) prophylaxis

    Date Reviewed: July 26, 2014
    Support
    Group/Practice Individual Clinician

    Measure Info

    NQF 0405CMS 160NQF EndorsedCQMC Core Measure
    Measure Type: 
    Process
    Measure Steward: 
    National Committee for Quality Assurance
    Clinical Topic Area: 
    HIV
    Care Setting: 
    Outpatient
    Data Source: 
    Other

    ACP supports NQF 0405: “HIV/AIDS: Pneumocystis jiroveci pneumonia (PCP) Prophylaxis” because it aligns with current US Department of Health and Human Services guidelines for the prevention of opportunistic infections in those diagnosed HIV/AIDS.